The launch of more new stimulation devices for conditions like epilepsy that are challenging to treat medically is expected to drive growth in the global electrotherapy system market, particularly in North America. The Vercise Primary Cell (PC) and Vercise Gevia Deep Brain Stimulation (DBS) Systems with the Vercise Cartesia Directional Lead were introduced by Boston Scientific Corporation in January 2019. The U.S. Food and Drug Administration (FDA) has given its approval to a piece of technology that gives medical professionals complete control over the intensity, form, location, and direction of electrical stimulation used to treat Parkinson's disease (PD) symptoms.
Read More;
https://knackersblogger.blogspot.com/2022/08/electrotherapy-system-market-size-share.html
Click here for Electrotherapy System Market Press Release:
